The members of the Seaflower investment team bring substantial prior operating experience from senior management roles in venture-backed and publicly traded biopharmaceutical companies.

Our investment team has a unique combination of technical, industry, financial and entrepreneurial expertise across all of our targeted life science and medical technology investment segments. Seaflower's partners work as a team to evaluate new investment opportunities and to support existing portfolio companies.